Literature DB >> 12370999

Medical management of pulmonary disease caused by Mycobacterium avium complex.

Michael D Iseman1.   

Abstract

The current medical therapy for Mycobacterium avium complex is controversial. American Thoracic Society recommendations advocate empiric therapy with drug susceptibility testing only for clarithromycin. At National Jewish, where we mainly see cases complicated by treatment failure and drug intolerance, we use in vitro susceptibility testing and therapeutic drug monitoring to optimize efficacy and reduce toxicity.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12370999     DOI： 10.1016/s0272-5231(02)00023-0

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  6 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

2.  ATP synthase inhibition of Mycobacterium avium is not bactericidal.

Authors:  Nacer Lounis; Tom Gevers; Joke Van den Berg; Luc Vranckx; Koen Andries
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

3.  Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.

Authors:  Irma A J M Bakker-Woudenberg; Wim van Vianen; Dick van Soolingen; Henri A Verbrugh; Michiel A van Agtmael
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Targeted delivery of amikacin into granuloma.

Authors:  Ana Montes-Worboys; Scott Brown; Doron Regev; Brendan F Bellew; Kamal A Mohammed; Ibrahim Faruqi; Parvesh Sharma; Brij Moudgil; Veena B Antony
Journal:  Am J Respir Crit Care Med       Date:  2010-08-06       Impact factor: 21.405

Review 5.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections.

Authors:  Ren-Tian Cai; Feng-Xue Yu; Zhen Tao; Xue-Qin Qian; Jun Chen; Hong-Zhou Lu
Journal:  Infect Dis Poverty       Date:  2017-11-02       Impact factor: 4.520
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.